Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
32.00    -0.75 (-2.29%)
Bid:
31.00
Ask:
33.00
Spread: 2.00 (6.452%)
Market Cap: £57.87m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Contract win

14 Aug 2014 07:00

RNS Number : 0875P
Ilika plc
14 August 2014
 



 

Ilika plc

("Ilika" or the "Company")

 

Contract win

 

Ilika (AIM: IKA), the accelerated materials innovation company, announces that it has entered into a commercial contract with a new customer, based in the EU, for the development of battery materials.

 

This six month contract takes the level of committed revenue for the current financial year to over £825k, which is significantly ahead of the £535k committed revenue at the same point last year.

 

Commenting on the contract, Graeme Purdy, CEO of Ilika, said: "This programme is a further demonstration of the strength of Ilika's technology platform for the development of leading edge lithium ion battery materials. It also continues the progress that we have made in attracting and retaining customers in Europe."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan, Nominated Adviser

 

James Black, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Paul Cornelius

Mob: 07827 879 460

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUORWRSRAWAAR
Date   Source Headline
23rd Apr 20122:44 pmRNSHolding(s) in Company
23rd Apr 20128:01 amRNSDirector/PDMR Shareholding
20th Apr 201212:49 pmRNSGeneral Meeting Results
4th Apr 201212:26 pmRNSPosting of circular
4th Apr 20127:00 amRNSPlacing and Subscription
13th Mar 20127:00 amRNSContract Renewals and Trading Update
2nd Feb 20127:00 amRNSJoint Development agreement with Energizer
10th Jan 20127:00 amRNSHalf Yearly Report
9th Jan 20127:00 amRNSNew contract with Toshiba
6th Dec 20117:00 amRNSAltrika grant award and new JDP
28th Nov 20117:00 amRNSSolid State Battery Development
16th Nov 20117:00 amRNSTrading Update
29th Sep 20118:21 amRNSFirst US electronics contract / Expansion in Asia
13th Sep 20115:06 pmRNSResult of AGM
2nd Aug 20117:00 amRNSPosting of annual report
14th Jul 20117:00 amRNSFull Year Results
4th May 20117:00 amRNSTrading Update
18th Apr 20117:00 amRNSCarbon Trust Grant / New Customer Contract
4th Mar 20118:00 amRNSRenewal of Contracts
24th Feb 20112:56 pmRNSNotification of Interest
23rd Feb 201112:16 pmRNSNotification of Interest
19th Jan 20113:00 pmRNSDISTRIBUTION OF INTERIM ACCOUNTS FOR 2010
24th Nov 20107:00 amRNSInterim Results
29th Oct 20107:00 amRNSIlika awarded Carbon Trust R&D Grant
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
21st Oct 20107:00 amRNSAgreement with Ministry of Defence agency
20th Oct 20104:35 pmRNSAnnual Financial Report
20th Oct 20104:35 pmRNSAnnual Financial Report
8th Oct 201010:30 amRNSInternational Business Development Appointments
8th Sep 20107:00 amRNSRevenue Update and Contract Renewal
18th Aug 20104:13 pmRNSNotification of Interest
17th Aug 20107:00 amRNSTotal Voting Rights
5th Aug 20104:05 pmRNSHolding(s) in Company
28th Jul 20107:00 amRNSUK Government Grant for Skin Wound Treatment
15th Jul 20107:00 amRNSFuel Cell Materials Joint Development Project
15th Jul 20107:00 amRNSFinal Results
30th Jun 20107:00 amRNSDevelopment Project
16th Jun 20107:00 amRNSFuel cell catalyst scale-up agreement
10th Jun 201012:39 pmRNSInspection, Regulatory Authority for Skin Products
9th Jun 20109:25 amRNSIlika partners to develop business in China
2nd Jun 20104:25 pmRNSExercise of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20105:16 pmRNSGrant of Options
14th May 20108:02 amRNSAdmission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.